Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy

Cancer immunotherapy has revolutionized the field of cancer treatment in recent years. However, not all patients receiving cancer immunotherapy exhibit durable responses, and reliable, high-throughput testing platforms are urgently needed to guide personalized cancer immunotherapy. The ability of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ji, Chen, Chao, Wang, Lu, Xie, Mingjun, Ge, Xinyang, Wu, Sufan, He, Yong, Mou, Xiaozhou, Ye, Chenyang, Sun, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016336/
https://www.ncbi.nlm.nih.gov/pubmed/35449581
http://dx.doi.org/10.3389/fonc.2022.872531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016336/
https://www.ncbi.nlm.nih.gov/pubmed/35449581
http://dx.doi.org/10.3389/fonc.2022.872531

Ejemplares similares